Agenus Inc AGEN:NASDAQ

Last Price$1.49NASDAQ Previous Close - Last Trade as of 4:00PM ET 3/24/23
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$1.50 (6)
Ask (Size)$1.58 (25)
Day Low / HighN/A - N/A
Volume5.0 M
  • Latest Stories
  • Commentary and Analysis
Sector Update: Health Care Stocks Firm Late in Tuesday Trading
4:18PM ET 3/14/2023 MT Newswires

Health care stocks added to earlier gains Tuesday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both up 0.9%....

Sector Update: Health Care Stocks Posting Small Gains
2:08PM ET 3/14/2023 MT Newswires

Health care stocks were edging higher Tuesday afternoon, with the NYSE Health Care Index rising 0.1% while the Health Care Select Sector SPDR Fund (XLV)...

Sector Update: Health Care Stocks Gain Premarket Tuesday
9:21AM ET 3/14/2023 MT Newswires

Health care stocks were gaining premarket Tuesday. The Health Care Select Sector SPDR Fund (XLV) was 0.7% higher and the iShares Biotechnology ETF (IBB)...

Agenus Q4 Loss Narrows, Revenue Rises
7:56AM ET 3/14/2023 MT Newswires

Agenus (AGEN) posted a Q4 loss Tuesday of $0.24 per share, compared with a loss of $0.26 per share a year earlier. Analysts polled by Capital IQ expected...

-- Earnings Flash (AGEN) AGENUS Posts Q4 Revenue $28.4M, vs. Street Est of $17.8M
7:31AM ET 3/14/2023 MT Newswires

...

HC Wainwright Assumes Agenus at Buy With $8 Price Target
9:38AM ET 2/28/2023 MT Newswires

(AGEN) has an average buy rating and price target range of $5 to $8.30, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity...

Agenus Says Trial Results Showed 'Durable Responses' of Botensilimab, Balstilimab Combination in Colorectal Cancer
3:31PM ET 1/23/2023 MT Newswires

Agenus (AGEN) said Monday that data from a 70-patient group in a Phase 1b study of botensilimab combined with balstilimab to treat colorectal cancer showed...

Agenus Registers for Potential Secondary Offering of Up to 2 Million Common Shares
3:33AM ET 12/27/2022 MT Newswires

Agenus (AGEN) late Friday registered with the US Securities and Exchange Commission for the potential resale of up to about 2 million common shares by some...

--EF Hutton Starts Agenus With Buy Rating, Sets Price Target at $8.30
7:40AM ET 12/22/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

--EF Hutton Initiates Agenus With Buy Rating, Price Target is $8.3
7:59AM ET 12/08/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...